Teletherapy in the management of patients with age-related macular degeneration complicated by subfoveal neovascularisation: An overview

Frontiers of Radiation Therapy and Oncology

Volumn 30, Issue , 1997, Pages 229-237

  Hart, P M ^a   Archer, D B ^a   Chakravarthy, U ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED RADIOTHERAPY; HUMAN; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); RADIATION EXPOSURE; RADIATION RESPONSE; RADIOISOTOPE THERAPY; RETINA FOVEA; RETINA MACULA DEGENERATION; REVIEW; TREATMENT OUTCOME; VASCULARIZATION;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FOVEA CENTRALIS; HUMANS; MACULAR DEGENERATION; NEOVASCULARIZATION, PATHOLOGIC; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 0030630664     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (27)

1. Kahn HA, Moorehead HB: Statistics on blindness in the model reporting area 1969-1970. United States Department of Health, Education & Welfare, Publ No (NIH) 73-427. Washington, US Government Printing Office, 1973.
2. Macular Photocoagulation Study Group: Argon laser photocoagulation for neovascular maculopathy: Three year results from randomised clinical trials. Arch Ophthalmol 1986;104:694-701.
3. Macular Photocoagulation Study Group: Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Arch Ophthalmol 1991;109:1220-1231.
4. Brouty Boye D, Zetter BR: Inhibition of cell motility by interferon. Science 1980;208:516.
5. Gillies MC, Sarks JP, Beaumont PE, et al: Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alpha 2a and 2b. Br J Ophthalmol 1993;77:759-765.
6. Kirkpatrick JNP, Dick AD, Forrester JV: Clinieal experience with interferon alpha 2a for exudative age-related macular degeneration. Br J Ophthalmol 1993;77:766-770.
7. Guyer DR: Experimental therapies for exudative age-related macular degeneration. Am Acad Abstr 1995;102(suppl):60-67.
8. Thomas MA, Grand G, Williams DF, et al: Surgical management of sub-foveal choroidal neovascularisation. Ophthalmology 1992:99:952-968.
9. Berger AS, Kaplan AG: Clinical experience with the surgical removal of sub-foveal neovascular membranes. Ophthalmology 1992;99:969-976.
10. Chakravarthy U, Biggart JH, Gardiner TA, Archer DB, Maguire CJK: Focal irradiation of perforating eye injuries with iodine-125 plaques. Curr Eye Res 1989;8:1241-1250.
11. Chakravarthy U, Gardiner TA, Archer DB, Maguire CJF: A light microscopic and autoradiographic study of irradiated ocular wounds. Curr Eye Res 1989;8:227-247.
12. Plowman PN, Harnett AN: Radiotherapy in benign orbital disease. I. Complicated ocular angíomas. Br J Ophthalmol 1988;72:286-288.
13. Amoaku WMK, Frew LJ, Gardiner TA, Mahon JG, Archer DB: Early ultrastructural changes after low-dose x-irradiation in the retina of the rat. Eye 1989;3:638-646.
14. Chakravarthy U, Houston RF, Archer DB: Treatment of age-related sub-foveal neovascular membranes by teletherapy: A pilot study. Br J Ophthalmol 1993;77:265-273.
15. Finger PT: Radiotherapy for sub-retinal neovascularisation. Invest Ophthalmol Vis Sci 1995;36: S224; with Update Finger PT, Berson A: Special Interest Group Meeting, ARVO 1996.
16. Mendelsohn ME, Spaide RF, Abrahamson DH, Yanuzzi LA: Radiation therapy for wet macular degeneration. Am Acad Meet Abstr 1995; p 94.
17. Marcus D, Shiels C, Burch S, Bates D, Johnson M: The radiation of age-related macular degeneration (ROARMD) study. Invest Ophthalmol Vis Sci 1996;37:S224.
18. Friedrichsen EJ, Slater JD, Loredo LN, Yonemoto LT, Ing JJ. Garcia CA, Chu HH, Chan CK, Blacharski PA, Slater JM: Proton beam irradiation of sub-foveal choroidal neovascularisation in age-related macular degeneration. Invest Ophthalmol Vis Sci 1995;36:S224.
19. 90 plaque irradiation. Invest Ophthalmol Vis Sci 1995;36:S224; with Update Special Interest Group, ARVO 1996.
20. Takahashi M, Taniguchi T, Matsuda N, et al: Radiation therapy for choroidal neovascularisation. Invest Ophthal Vis Sci 1995;36:S224.
21. Bergink GJ, Deutman AF, Van Den Broek JFCN, Van Der Maazen RW: Radiation therapy for sub-foveal choroidal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1994;232:591-598;
22. with Update Docum Ophthalmol 1995;90:67-74.
23. Hart PM, Chakravarthy U, Houston RF, Archer DB, Mackenzie G: Experience of treating subfoveal CNVM with radiotherapy over a five-year period. Invest Ophthalmol Vis Sci 1996;37:S103.
24. Seery CM, Cathcart C, Abdelsalam A, Zarbin MA: Photon beam teletherapy for choroidal neovascularisation. Invest Ophthalmol Vis Sci 1996;37:S116.
25. Holz FG, Bellmann C, Engenhart R, Völker HE: External stereotactic focal irradiation therapy for sub-foveal choroidal neovascularisation. Invest Ophthalmol Vis Sci 1996;37:S116.
26. Honjo M, Mandai M, Matsuda N, Miyamota H, Ogura Y, Sasai K: Prospective evaluation of the effect of different doses of radiation for age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:S223.
27. Harris JR, Levene MB: Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 1976;120:167-171.